Timothy P. Walbert - 05 Apr 2023 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
05 Apr 2023
Net transactions value
$0
Form type
4
Filing time
06 Apr 2023, 19:04:15 UTC
Previous filing
06 Jan 2023
Next filing
14 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRM Stock Option (right to buy) Award $0 +34,000 $0.000000 34,000 05 Apr 2023 Common Stock 34,000 $24.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares vest in equal annual installments over a three year period such that the option is fully vested on the third anniversary of the date of grant (April 5, 2023).